Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...
The behavioral health investment industry has undergone profound changes in the last five years. From the dizzying heights of record-breaking funding to the sharp...
In the United States, the healthcare system faces a significant challenge: Too many people are not receiving the healthcare they need, and the situation...
For decades, behavioral health providers have operated in isolated silos, leaving patients to navigate a fragmented and often confusing system of care for substance...
In a bold move that is set to redefine the landscape of transcranial magnetic stimulation (TMS) therapy, Neuronetics acquisition of Greenbrook TMS marks a...
After years of groundbreaking clinical trials and high expectations from both the medical and psychedelic research communities, Lykos Therapeutics has received a disappointing response...